Autoimmune aspects of depigmentation in vitiligo.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Investigative Dermatology Symposium Proceedings

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/J.1087-0024.2004.00825.XPMID 14870989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic association of the catalase gene (CAT) with vitiligo susceptibility.

  2002cited by this paper
• Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. II. Role of TNF, Lymphotoxin-α1β2, Fas Ligand, and TNF-Related Apoptosis-Inducing Ligand1

  2002cited by this paper
• The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo.

  2002cited by this paper
• Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo

  2002cited by this paper
• Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells.

  2002cited by this paper
• Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo.

  2002cited by this paper
• Antigens derived from melanocyte differentiation proteins: self‐tolerance, autoimmunity, and use for cancer immunotherapy

  2002cited by this paper
• Decreased Photodamage and Low Incidence of Non-Melanoma Skin Cancer in 136 Sun-Exposed Caucasian Patients with Vitiligo

  2002cited by this paper
• Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2.

  2002cited by this paper
• Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. I. Involvement of an Apoptosis-Inducing Pathway1

  2002cited by this paper
• Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand.

  2002cited by this paper
• Interferon- (cid:1) Reduces Melanosomal Antigen Expression and Recognition of Melanoma Cells by Cytotoxic T Cells

  2002cited by this paper
• Ultraviolet Light (UV) Regulation of the TNF Family Decoy Receptors DcR2 and DcR3 in Human Keratinocytes

  2001cited by this paper
• Autoimmune Melanocyte Destruction in Vitiligo

  2001cited by this paper
• 'VIT1', a novel gene associated with vitiligo.

  2001cited by this paper
• Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents.

  2001cited by this paper
• Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine

  2001cited by this paper
• A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo.

  2001cited by this paper
• Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

  2000cited by this paper
• Melanocyte Destruction after Antigen-Specific Immunotherapy of Melanoma

  2000cited by this paper
• Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other".

  2000cited by this paper
• Local Immune Response in Skin of Generalized Vitiligo Patients

  2000cited by this paper
• Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway.

  2000cited by this paper
• Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo

  2000cited by this paper
• Accumulation of identical T cells in melanoma and vitiligo-like leukoderma.

  1999cited by this paper
• A role for a melanosome transport signal in accessing the MHC class II presentation pathway and in eliciting CD4+ T cell responses.

  1999cited by this paper
• Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

  1999cited by this paper
• High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo

  1998cited by this paper
• Relative contributions of decay accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 in the protection of melanocytes from homologous complement.

  1998cited by this paper
• The use of melanosomal proteins in the immunotherapy of melanoma.

  1998cited by this paper
• Melanin-concentrating hormone binding sites in human SVK14 keratinocytes.

  1997cited by this paper
• Recent investigations on vitiligo vulgaris.

  1997cited by this paper
• Melanosomal proteins as melanoma-specific immune targets.

  1997cited by this paper
• Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.

  1996cited by this paper
• Vitiligo is associated with HLA-A2 and HLA-Dw7 in the Slovak populations.

  1996cited by this paper
• In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo.

  1995cited by this paper
• High frequency of thyroid dysfunction in patients with vitiligo.

  1994cited by this paper
• Melanocyte destruction and repopulation in vitiligo.

  1994cited by this paper
• A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders.

  1993cited by this paper
• Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation.

  1993cited by this paper
• HLA associations in vitiligo patients in the Dutch population.

  1993cited by this paper
• Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo.

  1991cited by this paper
• Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients.

  1991cited by this paper
• Successful culture of adult human melanocytes obtained from normal and vitiligo donors.

  1990cited by this paper
• Occupational Vitiligo Due to Unsuspected Presence of Phenolic Antioxidant Byproducts in Commercial Bulk Rubber

  1988cited by this paper
• Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity.

  1988cited by this paper
• Vitiligo in the Ssk Community of Bangalore (a Preliminary Report).

  1988cited by this paper
• Vitiligo in patients with metastatic melanoma: a good prognostic sign.

  1983cited by this paper
• Antibodies to normal human melanocytes in vitiligo

  1983cited by this paper
• Vitiligo and Other Hypomelanoses of Hair and Skin

  1983cited by this paper

• Predictive analysis of vitiligo treatment drugs using degree and neighborhood degree-based topological descriptors

  2025cites this paper
• Study of cathelicidin (LL-37) immunoexpression in the skin of vitiligo patients

  2025cites this paper
• The immunological pathogenesis of vitiligo and the potential role of mesenchymal stromal/stem cells in its treatment

  2025cites this paper
• Anti-Thyroid Peroxidase Antibody and Segmental Vitiligo

  2024influential citation
• Association between FOXP3 (rs3761548) promoter polymorphism with vitiligo patients, their clinical data and response to phototherapy: A study from Egypt

  2022cites this paper
• Regenerative Medicine-Based Treatment for Vitiligo: An Overview

  2022cites this paper
• The Role of NKG2D in Vitiligo

  2021cites this paper
• Immune‐modulatory effects of lenalidomide inhibited the progression of lesions in a vitiligo mouse model

  2021cites this paper
• Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors

  2021cites this paper
• Evaluation of High Mobility Group Box 1 In Vitiligo Patients

  2021cites this paper
• Contribution of HLA class II genes, DRB4*01:01, DRB1*07:01, and DQB1*03:03:2 to clinical features of Vitiligo disease in Iranian population

  2021cites this paper
• ISSN: 2595-573X

  2021cites this paper
• Acquired Idiopathic Generalized Anhidrosis (AIGA) and Its Complications: Implications for AIGA as an Autoimmune Disease

  2021cites this paper
• Efficacy of topical calcipotriol betamethasone dipropionate as a new adjuvant therapy to follicular unit extraction technique in treatment of stable vitiligo: clinical, dermoscopic and immunohistological study

  2021cites this paper
• NEED OF VITAMIN D BEYOND BONE: A CONSISE REVIEW

  2021cites this paper
• Novel immunological and genetic factors associated with vitiligo: A review

  2021cites this paper
• The relationship between stress and vitiligo: Evaluating perceived stress and electronic medical record data

  2020cites this paper
• Antigen Specificity Enhances Disease Control by Tregs in Vitiligo

  2020cites this paper
• Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.

  2020influential citation
• Increased level of cathelicidin (LL‐37) in vitiligo: Possible pathway independent from vitamin D receptor gene polymorphism

  2020cites this paper
• Randomized controlled trial of topical corticosteroid and home‐based narrowband ultraviolet B for active and limited vitiligo: results of the HI‐Light Vitiligo Trial *

  2020cites this paper
• Immune modulatory effects of lenalidomide on the cultured peripheral blood mononuclear cells from vitiligo patients

  2020cites this paper
• Topical olive oil with downregulation of stress factors protects mice skin from precarious 3600 MHz electromagnetic radiation.

  2020cites this paper
• Efficacy of microneedling combined with tacrolimus versus either one alone for vitiligo treatment

  2020cites this paper
• RNA-seq Reveals Dysregulation of Novel Melanocyte Genes upon Oxidative Stress: Implications in Vitiligo Pathogenesis

  2019cites this paper
• Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy

  2018cites this paper
• Inflammation drives nitric oxide synthase 2 expression by γδ T cells and affects the balance between melanoma and vitiligo associated melanoma

  2018cites this paper
• Identification of the Risk HLA-A Alleles and Autoantigen in Han Chinese Vitiligo Patients and the Association of CD8+T Cell Reactivity with Disease Characteristics

  2018cites this paper
• PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin

  2018cites this paper
• Thyroid Dysfunction in Non-segmental versus Segmental Vitiligo

  2018cites this paper
• Down-regulation of MBD4 contributes to hypomethylation and overexpression of CD70 in CD4+ T cells in systemic lupus erythematosus

  2017cites this paper
• Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: A multi‐institutional retrospective study

  2017cites this paper
• Vitíligo como marcador clínico de respuesta a pembrolizumab en un paciente con melanoma metastásico

  2017cites this paper
• Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets

  2017cites this paper
• Evaluation of the effect and mechanism of action of local phenytoin in treatment of vitiligo

  2017cites this paper
• Vitiligo pathogenesis is interlinked with pigment homeostasis: A new concept

  2017cites this paper
• Association of VitiligoWith Tumor Response in Patients WithMetastatic Melanoma TreatedWith Pembrolizumab

  2016cites this paper
• The Evaluation of Endothelin-1 and Endothelin Receptor Type A Gene Polymorphisms in Patients with Vitiligo

  2016cites this paper
• Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab.

  2016cites this paper
• The effect of ER:YAG plus 5-fluorouracil on the outcome of punch grafting in nonsegmental vitiligo: a left–right comparative study

  2016cites this paper
• Resident T cells in human skin : functional heterogeneity and clinical implications

  2016cites this paper
• Evaluation of the correlation between serum levels of vitamin D and vitamin D receptor gene polymorphisms in an Egyptian population

  2016cites this paper
• Vitiligo: new etiology-based treatments

  2016cites this paper
• Screening of Glaucoma or Cataract Prevalence in Vitiligo Patients and Its Relationship With Periorbital Steroid Use

  2016cites this paper
• The changes of gene expression profiling between segmental vitiligo, generalized vitiligo and healthy individual.

  2016cites this paper
• Anatomical segmentations in all forms of vitiligo: A new dimension to the etiopathogenesis

  2016cites this paper
• A functional single‐nucleotide polymorphism in the ERCC1 gene alters the efficacy of narrowband ultraviolet B therapy in patients with active vitiligo in a Chinese population

  2015cites this paper
• Association of ApaI and BsmI polymorphisms with vitiligo risk: a meta‐analysis

  2015cites this paper
• Epigenetics and Other Autoimmune Skin Diseases

  2015cites this paper
• Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes

  2015cites this paper
• Vitamin D and skin diseases: A review.

  2015cites this paper
• Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo

  2015cites this paper
• A case-control study: evaluation of vitamin D metabolism in patients with vitiligo.

  2015cites this paper
• The additive effect of excimer laser on non‐cultured melanocyte–keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population

  2015cites this paper
• The combination of tumour necrosis factor‐α −308A and interleukin‐10 −1082G gene polymorphisms and increased serum levels of related cytokines: susceptibility to vitiligo

  2015cites this paper
• Alopecia Areata and Vitiligo as Primary Presentations in a Young Male with Human Immunodeficiency Virus

  2014cites this paper
• Assessment of tissue FoxP3+, CD4+ and CD8+ T‐cells in active and stable nonsegmental vitiligo

  2014cites this paper
• Vitiligo - Part 1

  2014cites this paper
• Effect of narrow band‐ultraviolet B on CD4+ CD25high FoxP3+T‐lymphocytes in the peripheral blood of vitiligo patients

  2014cites this paper
• Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells

  2014cites this paper
• Reactive Oxygen Species and Reactive Nitrogen Species in Vitiligo

  2014cites this paper
• Study of the Serum Level of the Monokine Induced by Interferon Gamma (MIG) in Vitiligo Patients

  2014cites this paper
• Association of FAS Gene Promoter Functional Polymorphisms and the Risk of Vitiligo in Turkish Populations

  2014cites this paper
• Segmental and Generalized Vitiligo: Both Forms Demonstrate Inflammatory Histopathological Features and Clinical Mosaicism

  2013cites this paper
• Immunohistochemical expression of heat shock protein 70 in vitiligo.

  2013cites this paper
• Vitiligo: clinical aspects, quality of life and the role of melanocortin system in pathogenesis

  2013cites this paper
• This information is current as Fas-Fas Ligand Interactions Spontaneous Vitiligo and Depends upon a Melanocyte Neoantigen Induces CD4 T Cell-Dependent Autoimmunity against

  2013cites this paper
• Vitiligo: Clinical Presentation and Management

  2013cites this paper
• Setting priorities and reducing uncertainties for the treatment of vitiligo

  2013cites this paper
• Decreased regulatory T‐cells and CD4+/CD8+ ratio correlate with disease onset and progression in patients with generalized vitiligo

  2013cites this paper
• Analysis of Vitamin D Receptor Gene Polymorphisms in Vitiligo

  2012cites this paper
• An Investigation of Autoantibodies against Tyrosine Hydroxylase in Patients with Vitiligo

  2012cites this paper
• Narrowband Ultraviolet B Phototherapy in Childhood Vitiligo: Evaluation of Results in 28 Patients

  2012cites this paper
• Acquired patch‐type blue nevus with overlying vitiligo: a case report

  2012cites this paper
• The association of vitamin D receptor gene polymorphisms and serum 25‐hydroxyvitamin D levels with generalized vitiligo

  2012cites this paper
• A pattern of association between clinical form of vitiligo and disease-related variables in a Brazilian population.

  2012cites this paper
• Ethanomedicinal trends in Indian tradition for treatment of vitiligo

  2012cites this paper
• Chemoprevention of Familial Melanoma

  2011cites this paper
• Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment

  2011cites this paper
• Immunopathogenesis of vitiligo.

  2011cites this paper
• Th17 Cells and Activated Dendritic Cells Are Increased in Vitiligo Lesions

  2011cites this paper
• A double‐blind, randomized, placebo‐controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo

  2011cites this paper
• Generalized vitiligo in a pure-bred Rottweiler: case report

  2011cites this paper
• Pathophysiology and prevention of photoaging : the role of melanin, reactive oxygen species and infiltrating neutrophils

  2011cites this paper
• Maintenance of immune hyporesponsiveness to melanosomal proteins by DHICA-mediated antioxidation: Possible implications for autoimmune vitiligo.

  2011cites this paper
• Vitiligo: pathogenetic hypotheses and targets for current therapies.

  2010cites this paper
• Shared Genetic Relationships Underlying Generalized Vitiligo and Autoimmune Thyroid Disease

  2010cites this paper
• Abnormal DNA methylation in peripheral blood mononuclear cells from patients with vitiligo

  2010cites this paper
• Genetics of psoriasis and vitiligo, focus on IL10 family cytokines

  2010cites this paper
• Función del peróxido de hidrógeno en el vitíligo

  2010cites this paper
• Function of hydrogen peroxide in cases of vitiligo

  2010cites this paper
• On the role of dendritic cells in the pathogenesis of vitiligo

  2010cites this paper
• Severe Combined Immunodeficiency (SCID)‐Associated Dyschromia with Subsequent Repigmentation: A Report of Two Patients

  2009cites this paper
• A functional single-nucleotide polymorphism in the catechol-O-methyltransferase gene alter vitiligo risk in a Chinese population

  2009cites this paper
• Imiquimod‐induced vitiligo after treatment of nodular basal cell carcinoma

  2009cites this paper
• Evaluation of Circulating CD4 + CD25 high Foxp3 + T-Lymphocytes in Active Non-Segmental Vitiligo

  2009cites this paper
• Phototherapeutic Options for Vitiligo

  2009cites this paper
• MART-1 transcript is absent in PBMCs from Vitiligo patients

  2009cites this paper
• New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo

  2009cites this paper
• A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases.

  2008cites this paper